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PREVIOUS work has shown that mitochondria prepared from certain tumour
strains in isotonic sucrose containing 0.001 M EDTA,* exhibited higher ATP-
andDPN-splitting activities than the mitochondria from othertumours (Emmelot,
Bos and Brombacher, 1956). When the former were added to fresh liver mito-
chondria, the octanoate- or BHB-oxidation of the liver mitochondria became
completely inhibited in the combined system (Emmelot and Bos, 1955a, 1955b,
1956a). ItwasfoundthattheDPNase inhibitorNAA, orDPNitself, re-established
the oxidation when the D-isomer of BHB served as a substrate in the combined
system of liver and tumour mitochondria (Emmelot and Bos, 1955b, 1956a).
The oxidation ofthe L-isomer of BHB, however, still remained blocked under the
latter conditions. This difference in behaviour of the liver mitochondria in the
presence ofthe tumour mitochondria in respect to the oxidation ofthe two isomers
was explained on account of the co-factors necessary for oxidation, which have
been shown to be dissimilar (Lehninger and Greville, 1953). The latter authors
found that the oxidation of D-BHB by rat liver mitochondria proceeded inde-
pendently of ATP in that the free acid was oxidized, whereas L-BHB needed
ATP for the formation of its CoA-derivative, L-BHByl-CoA being the form in
which the L-isomer was oxidized. DPN acted as coenzyme of both the D-BHB
and the L-BHByl-CoA dehydrogenases.
Thus, by adding DPN to the combined system of liver and tumour mito-
chondria, the oxidation of D-BHB might easily be repaired, but the "ATPase"
activities of the tumour mitochondria would render the oxidation of L-BHB
impossible by depriving the liver mitochondria ofATP.
In the present communication direct evidence is presented for the uncoupling
action of certain tumour mitochondria on the phosphorylative processes of the
liver mitochondria. Related experiments dealing with the phosphate release from
ATP and ADP by these and other tumour mitochondria under various experi-
mental conditions are also described and compared with the results obtained with
mouse liver mitochondria.
MATERIALS AND METHODS
Tissues.-Livers were collected from mice of several inbred strains and their
F1 hybrids. Unless otherwise statedtransplanted mouse tumours which have been
described previously (Emmelot and Bos, 1955a) were used.
* Abbreviations are used as follows: EDTA = ethylendiamine tetracetate; AMP, ADP,
ATP = adenosine mono-, di- and triphosphates; "ATPase" = adenosine triphosphatase; DPN
= disphosphopyridine nucleotide; DPNase and TPNase = di- and triphosphopyridine nucleo-
sidase; NAA = nicotinamide; BHB = P-hydroxybutyrate; CoA = Coenzyme A; Pi = inorganic
orthophosphate; P: O = ratio of micro-moles of inorganic phosphate esterified to the micro-
atoms of oxygen utilized; 2: 4-DNP = 2: 4-dinitrophenol.STUDIES ON TUMOUR MITOCHONDRIA
Preparation of mitochondria.-Liver mitochondria were isolated in 0.25 M
sucrose and tumour mitochondria in 0.25 M sucrose containing 0.001 M EDTA
pH 7.4. The mitochondrial pellets, which were spun down by centrifugation at
0° C. during 10 minutes at 5000 X g after removal of nuclei and cell d6bris, were
always washed twice by resuspension and centrifugation at 18,000 x g. Special
care was taken to remove the fluffy layer as completely as possible.
Preparation of mitochondrial sub-fractions.-Mitochondria from 1 g. of tissue
were suspended in 1 ml. of distilled water during 60 minutes at room temperature.
The swollen mitochondria were then disrupted by homogenization for 1 minute,
with pyrex glass powder in a tight-fitting homogenizer of the Potter-Elvejhem
type held in cracked ice. Centrifugation for 5 minutes at 700 x g was carried
out to remove the glass powder, followed by 30 min. at 20,000 X g. The latter
procedure yielded a pellet and a supernatant. The supernatant was clear yellowish
in the case of liver mitochondria but (faintly) turbid in the case of tumour mito-
chondria. The pellet was washed once with 2 ml. of distilled water. Pellet and
combined supernatants were then made up with distilled water in the relation
1: 2 respectively to the smallest volume possible. 0.1 ml. (pellet) and 0-2 ml.
(supernatant) aliquots were added to the Tris-KCl-MgCl2 medium of Chappell
and Perry (1954) which contained either ADP (0-005 M) or ATP (0.005 M). Final
pH 7.4. Incubation was carried out at 27° C. for 20 minutes.
In a number ofexperiments, after removal ofthe glass powder, the suspension
of the disrupted mitochondria was brought to pH 5.0 with 1 per cent of acetic
acidandcentrifuged. Theresultingsub-fractionswereneutralizedwithdilute KOH.
It was not investigated whether under the conditions chosen for the disruption
of the mitochondria maximal recoveries of the activities were obtained. In fact
it is suspected that part of the enzymes are inactivated due to the local heating
by friction during the energetic grinding of the particles.
Determinations.-Inorganic phosphate release from ADP and ATP by whole
mitochondria was measured under the same conditions as those described for the
sub-fractions. Care was taken to use approximately similar quntities of mito-
chondria (based on mg. nitrogen) in the experiments since the ATPase activites
have been shown not to be proportional to enzyme concentration. The specific
activities of the ATPase were smaller the higher the enzyme concentration used.
Phosphate was determined by the method of Fiske and Subbarow (1929).
The conventional Warburg technique was used to measure oxygen uptake during
oxidation of DL-hydroxybutyrate or pyruvate at 27° C. Acetoacetate was deter-
mined according to Thin and Robertson (1952). ATP and ADP were products
from Zellstoffabrik Waldhof (Wiesbaden-Germany); the compounds were 75
and 80 per cent pure as assayed enzymatically with hexokinase plus glucose-6-
phosphate dehydrogenase (mouse liver) in the absence and presence of myokinase
(rabbit muscle), respectively. DPN (95 per cent pure) was obtained from Boeh-
ringer u.S. (Mannheim, Germany) and freshly prepared human serum y-globulin
and albumin from the Central Laboratory of the Netherlands Red Cross
(Amsterdam). Another albumin preparation obtained from the same Laboratory
five years ago had been kept at room temperature by us; it was slightly yellow
coloured and is designated in the text as aged albumin. Neutral solutions of the
proteins were added in a final concentration of 2 per cent.
The experiments illustrated in the tables and figures are representative
examples from several test series.
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RESULTS AND DISCUSSION
Oxidative phosphorykation in a combined liver-tumour mitochondrial system
If DPN addition re-establishes the oxidation of the D-isomer but not that of
the L-isomer ofBHB inthe combinedliver-tumour mitochondrial system incubated
in the presence ofDL-BHB, only 50per cent ofthe theoretical oxygen consumption
necessary for the conversion of DL-BHB to acetoacetate may be expected. This
was actually found. Acetoacetate production was likewise approximately half
of that shown by the liver mitochondria incubated separately. Table I illustrates
one suchexperment in which the mitochondria from the adrenal cortex carcinoma
T17572 were used. It should be noted that the tumour mitochondria per se
were not able to oxidize DL-BHB under the conditions used in these experiments.
TABLE I.-Oxidation ofDL-,8-hydroxybutyrate by Liver Mitochondria Incubated
Separately and Together with Tumour Mitochondria
0-3 ml. of a liver mitochondrial suspension in 0.25 M sucrose was added to
Warburg flasks containing 100 u-moles KC1, 21 Vu-moles K-phosphate
bufferpH 7.4, 10 p-moles ATP, 0-01 i.-moles cytochrome C and 35 u-moles
MgSO.
0'3 ml. of a tumour mitochondrial suspension in 0.25 M sucrose containing
0.001 MEDTA was added to two oftheseflasks. In one ofthe latterflasks
in addition 1*6 u-moles DPN were present. After temperature equilibra-
tion 12 u-moles DL-BHB were tipped in. Total volume ] 6 ml. The
centre well contained 0.1 ml. 3NKOH. Incubated 60 minutes at 27° C.
N present Oxygen Acetoacetate
Mitochondria per flask uptake formation
from (mg.) ([z-atoms) (,u-moles)
Liver . . . . 1.55 . 12.0 . 10.0
Liver+T17572 . . . 1-55+124 . 0 2 . 0.3
Liver + T17572 + DPN . 1-55+1.24 . 6-6 . 5-2
That theATP-dependent oxidation ofthe L-isomer ofDL-BHB remained blocked
was proven byexperiments in whichthe isomers ofBHB were incubated separately
with the combined liver-tumour mitochondrial suspensions (Emmelot and Bos,
1956a). The nature of this inhibition has now clearly been demonstrated by
measuring thephosphateuptake duringthere-establishedoxidation ofthe D-isomer
in a DPN-fortified liver-tumour mitochondrial system incubated with DL-BHB.
As illustrated in Column 4 of Table II no net uptake ofPi occurred during this
oxidation. The P: 0 ration of 0.1 which was found illustrated that the tumour
mitochondria acted as uncouplers of the phosphorylations association with the
oxidation of D-BHB by the liver mitochondria. Hence no ATP became available
for the required conversion of L-BHB to L-BHByl-CoA and, in consequence,
the oxidation of this isomer remained depressed.
Similar results were obtained with the mitochondria from other tumours,
like the sarcoma UV256, the sarcomatoid ovarian tumour T24202 and primary
azodye-induced rat hepatomas and transplants thereof.
In the present experiments oxygen and phosphate uptakes were measured
after 15 minutes of incubation. During this period both the oxidation of BHB
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TABLE II.-Oxidative Phosphorylation of Liver Mitochondria Incubated Separately
and Together with Tumour Mitochondria
Experimental conditions as in Table I. Instead of ATP 10 ,u-moles ADP
were present. The ,-moles Pi were lowered to ]4-4. From the side arm
of the flasks 12 ,-moles DL-BHB, 40 t-moles glucose and 30 Kunitz-
McDonald units hexokinase were added. Incubated for 15 minutes
at 27° C.
N present
Mitochondria per flask Pi found - A Pi - AO
from (mg.) DL-BHB (V-moles) ([i-moles) (,u-atoms) P: 0O
Liver 1.46 aAbsent 13.5f . 3.9 . 3.0 . 1.3
fPresent . 9 6
Liver +T17572 1-46+1.06 .Absent . 18.1 . 0.2 . 2.1 . .1
+ DPN fPresent . 17*9
by the liver mitochondria and that by liver plus tumour mitochondria with
DPN present, is incomplete. The liver mitochondria showed P: 0 ratios in the
range of 1-2-1-5 (in the experiment illustrated in Table II a ratio of 1.3 was found).
The latter values may be higher when fluoride is added. In the present type of
experimentsfluoride hadtobeabsentforobvious reasons. Intheearlier experiments
(Emmelot and Bos, 1955b, 1956a; compare Table I) ATP was added instead
of ADP and under this condition it was found that the oxidation of DL-BHB
or D-BHB by the liver-tumour mitochondrial system fortifiedwithDPN, proceeded
initially at a higher rate than the oxidation of the liver mitochondrial controls.
This could have been due to the "ATPase "activities ofthe tumour mitochondria
since it is known that a "high energy" phosphate trapping system enhances
mitochondrial oxidations. Now that ADP was used as phosphate acceptor in
the present experiments the oxidation in the liver-tumour mitochondrial system
was equal to or somewhat less than thatshown bythe livermitochondria incubated
separately. This observation might give some weight to the above assumption.
In further experiments it was found that fluoride (0.01 M) partly relieved the
inhibition exerted by the tumour-mitochondria on the liver mitochondrial
oxidation of DL-BHB in the absence of DPN (Emmelot and Bos, 1956b). When
the two isomers were studied separately it appeared that fluoride addition repaired
the oxidation ofthe D-isomer, as showninTableIII.
TABLE III.-Effect of Fluoride on the Oxidation of D-/-hydroxybutyrate by Liver
Mitochondria Incubated Together with Tumour Mitochondria
Experimental conditions as in Table I. In this case 5 ,u-moles D-BHB were
added. 16 ,-moles NaF were present as indicated in the table.
N present Oxygen Acetoacetate
Mitochondria per flask uptake formation
from (mg.) (qt-atoms) (.-moles)
Liver . . 1-52 101 4.0
Liver+T17572 . . 52+0- 97 0 . -*
Liver+T17572+DPN . 152+0-97 5-2 . 4- 5
Liver+T17572+F . 1-52+0-97 4.9 . 4-4
The nature of the fluoride effect would thus involve a direct inhibition of the
tumour mitochondrial DPNases. However, some evidence accumulated (Emmelot
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and Brombacher, 1956a) that the effect of fluoride could also be explained on
account of its potent inhibitory action on the tumour mitochondrial "ATPases ":
by protecting the "high-energy" phosphate fluoride would indirectly stabilize
the biochemical integrity of the mitochondria and thus counteract the develop-
ment of the DPNases. Table IV illustrates that in the combined liver-tumour
mitochondrial system with fluoride present, a net synthesis of ATP did indeed
take place during the oxidation of DL-BHB.
TABLE IV.-Effect of Fluoride on the Oxidative Phosphorylation of Liver Mito-
chondria Incubated Together with Tumour Mitochondria
This experiment belongs to the series illustrated in Table II. Sixteen
v-moles NaF were present.
Mitochrondria Pi found - APi - AO
from DL-BHB (u-moles) ([z-moles) (Q-atoms) P: O
Liver+T17572+F Present 13-7 2. 8 . 1*3 Prsn 11 ''2
It might now be expected that fluoride would also counteract the inhibition
of the oxidation of L-BHB in the combined liver-tumour mitochondrial system.
However an effect of fluoride on this oxidation was difficult to demonstrate:
only in a few experiments a small oxidation was found. This discrepancy may be
understandable inviewoftheinhibitoryeffectoffluorideoncertainMg2-dependent
reactions. Although by its same virtue, fluoride inhibits the ATPase and thus
protects the ATP necessary for the formation of the L-BHByl-CoA bond, it might
also easily inhibit the same reaction which is Mg2+-dependent. This action of
fluoride explained some ofour earlier findings regarding the oxidation ofoctanoate
(Emmelot and Bos, 1955a); Aisenberg and Potter (1956) have recently provided
direct evidence for the inhibitory effect of fluoride on the formation of acetyl-
CoA from acetate by rat liver mitochondria.
Phosphate release from ADP and ATP catalyzed by liver and tumour mitochondria
Inspection ofthe data listed in Column 4 ofTable II shows that the concentra-
tion of Pi at the end of the 15 minutes' incubation of liver plus tumour mito-
chondria was higher (18 ,-moles) than that at the start of the experiment (14.4
,-moles). Any extra phosphate must have been derived from the only other
phosphate compound present, i.e. ADP, since in control experiments mitochondria
incubated in the absence ofADP didrelease onlyan insignificant amount ofPi.
ThePi release fromADPwas investigated inmore detail byincubating sucrose-
EDTA-prepared tumour mitochondria with ADP in the absence of oxidizable
substrate in the Tris-KCl-MgCl2 medium of Chappell and Perry (1954). Earlier
experiments had established that the "ATPases" of mitochondria isolated
from different tumour strains were not uniformly active: they varied from the
order shown by liver mitochondria to higher values (Emmelot, Bos and Brom-
bacher, 1956). Table V shows that the particles followed the same relative
order of activities in releasing Pi from ADP. Very pronounced activities were
inherent in that group of tumour mitochondria which uncoupled the oxidative
phosphorylations of the liver mitochondria.
Since the breakdown of ADP to P1i takes place through the combined action of
the two mitochondrial enzymes, myokinase (adenylate kinase) and ATPase
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TABLE V.-Phosphate Release from ADP Catalyzed by Tumour Mitochondria
Mitochondria isolated in 0.25 M sucrose--0001 M EDTA. Incubation at
27° C. in the Tris-KCl-MgCl2 medium of Chappell and Perry (1954).
Mitochondria
from
rP' r170 ___ n to + _ > A
N present
per flask
(mg.)
nA. ')Q
,u-moles Pi/mg. N released
after minutes 5
5
1 A . ri 1i,V iz lactUreIna! cortex carCllmoma) u·o . iu·u
0 23 . 11 6
TUV256 (sarcoma) . . . 0 20 . 55
T26473 (hepatoma) . . 0 25 . 6 1
BY256 (rat adenohepatoma) . ( 21 . 5 6
T5441 (granulosa celltumour ovary) 0 21 2 0
T26554 (interstitial cell carcinoma 0 21 . 2 3
testis)
Liver tmouse) . . . . 025-003 . 0 0-1 5
Liver (rat) . . . . 0 22 . 0.0
10 20 30
18 3 22 8 28 1
18 0 25 3 30.0
9-7 17 7 24 2
10 3 17 6 23 1
10-2 18 3 24 6
3-0 5.5 7 0
3 8 7 3 10.4
1-2-2-4 2-0-3.9 4.0-6-0
1.8 3.0 5.4
(2ADP -, ATP + AMP; ATP -+ ADP + Pi, etc.) both activities appear to
be high in these tumour mitochondria, which have been shown earlier to possess
also markedly active DPNases and TPNases (Emmelot and Brombacher, 1956b).
The group of tumour mitochondria that had been found in the earlier experi-
ments to be the most intact from the biochemical point of view, released very
much lessPi from ADP as illustrated by two representative experiments (testicular
tumour T26554 and ovarian tumour T5441) in Table V. These mitochondria did
not inhibit the fatty acid oxidation ofthe liver mitochondria and possessed smaller
DPNase and TPNase activities than the former tumour mitochondria (Emmelot,
Bos and Brombacher, 1956).
A competition for the ATP, formed from ADP by the myokinase, may be
expected between the "ATPases" of the tumour mitochondria and any other
"high energy" phosphate trapping system. As shown in Table VI, the amount
of Pi released from ADP is smaller the higher the concentration of hexokinase
that was added together with a constant quantity of glucose. Hexokinase con-
centrations higherthanthose listed inthe table did not alterthe results very much,
which indicated that the "ATPases" had a far more ready access to the ATP,
resulting from the myokinase action on ADP, than the soluble hexokinase.
TABLE VI.-Phosphate Release from ADP Catalyzed by Tumour Mitochondria
in the Absence and Presence of Hexokinase-glucose
Experiment 1: Mitochondria from UV256 sarcoma.
Experiment 2: Mitochondria from TI7572 adrenal cortex carcinoma.
Glucose0.025 M, hexokinase as indicated.
Hexokinase
Experi- (Kunitz-McDonald
ment No. units)
1 . 0
14
35
2 . 0 .
28
35
,u-moles Pi/mg. N after minutes
A
5
5-3
4-4
2 8
10 9.4
8 2
7 0
16 1
10.1
10.0
20
16 5
14 6
12 5
27-0
19 2
18 2
I
30
23 3
18 0
16.0
Sucrose-prepared mitochondria from mouse and rat liver acting upon ADP,
while suspended in the Tris-KCl-MgCl2 medium, were found to release a very
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small quantity of Pi from the nucleotide. The ranges of activity calculated per
mg. mitochondrial nitrogen for 5 experiments with mouse liver particles are
given in Table V. In a similar experiment conducted in isotonic sucrose with
rat liver mitochondria by Siekevitz and Potter (1953) noPi was found. Kielly and
Kielly (1951), Potter, Simonson and Siekevitz (1953) and others have shown that
the "ATPase" activity of freshly-prepared mouse and rat liver mitochondria
suspended in isotonic sucrose is extremely lowor completelyabsent (latent "ATP-
ase "). The "ATPase" of the fresh mouse liver mitochondria under the present
experimental conditions were not completely latent as shown in Fig. 1 (solid
lines) but agreed well with the findings of others (Wade and Jones, Jr., 1956).
Min.
FIG. 1.-The effect of y-globu]in on mouse liver mitochondrial
ATPases and their activation by 2: 4 DNP.
Isolation of mitochondria in 0 25 M sucrose, incubation at 27° C. in Tris buffer (005 M)
containing KCI (C 1 M), MgSO4 (0 005 M) and ATP (0 005 M). pH 7
- 4. 0 05 mg. mito-
chondrial N per flask.
* 0 controls, O 0O 2: 4-DNP (10-4 M) present, *---- y-
globulin (2 per cent) present, 0 -- -O y-globulin + 2: 4-DNP present.
Underthe conditions ofthe earlierexperiments (Emmelot, BosandBrombacher,
1956) we were unable to find any activation of the tumour mitochondrial "ATP-
ases" in the presence of 2: 4-IDNP and only a two-fold activation of the corre-
sponding activities of the liver mitochondria was observed. The 2: 4-DNP
activation has now been studied with small amounts of sucrose mitochondria
and using y-globulin to afford some protection against the degenerative changes
which are suffered by the mitochondria in vitro. In experiments with the sucrose
mitochondria from 25 mg. of mouse liver, 2 per cent y-globulin was found to sup-
press the spontaneous activation of the latent "ATPases" as shown in Fig. 1
(compare Wade and Jones, Jr., 1956). It has further been observed that 2: 4-DNP
(10-4 M) activates the "ATPases " of our liver preparations to a greater extent
in the presence ofy-globulin than in its absence (Fig. 1).
The active ATPases of the sucrose-EDTA mitochondria from the adrenal
cortex carcinoma T17572 could be also suppressed by y-globulin but only during
the finst 10 minutes of incubation (Fig. 2). 2: 4-DNP (10-4 M) did activate the
tumour mitochondrial ATPases under the latter conditions and caused a phosphate
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FIG. 2.-The effect of y-globulin on tumour mitochondrial ATPases (mouse adrenal cortex
carcinoma T 17572) and their activation by 2: 4-DNP.
Isolation in 0 25 M sucrose containing 0 001 M EDTA (pH 7.4) 0 05 mg. mitochondrial
N per flask. Compare Fig. 1.
release which was of the same order as that shown by the mitochondria in the
absence of the protective protein. The less active ATPases of the sucrose-EDTA
mitochondria from the hepatoma T28012 were markedly lower in the presence of
y-globulin during the whole 20-minute incubation period. 2: 4-DNP activated the
ATPases to a marked extent under the latter conditions (Fig. 3).
Anunexpected stimulating effectonthemitochondrialATPaseswasfoundwhen
the suspension medium was supplemented with 2 per cent aged human serum
albumin. This preparation had been kept in our laboratory for some five years
at roomn temperature. The aged albumin was found to activate the liver mito-
chondrial ATPases in the same manneras 2: 4-DNP. The activation ofthe tumour
mitochondrial ATPases was especially significant after the first 5 minutes and
decreased in proportion when the incubation was carried out longer (Fig. 4).
2: 4-DNP did not activate the ATPases of the liver or tumour mitochondria
furtherwhentheagedprotein was present. Theeffectofthe preparation is contrary
to the protection that may be expected to arise from the addition of fresh albumin
and that was indeed also found. When incubated separately with ATP the aged
albumin did not cause Pi release and neither did it affect the pH ofthe suspension
medium during the incubation. The latter was rigorously controlled since the
ATPase activities of the tumour mitochondria, like those of liver mitochondria
(Swanson, 1956), have been found (unpublished observations) to vary with the
pH of the medium. After cold extraction with petrol-ether the aged albumin
still exhibited its effect. The extract was evaporated but the small amount of
fatty residue did not produce any activation of the ATPases of the liver mito-
chondria.
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FIG. 3.-The effect of y-globulin on tumour mitochondrial ATPases (mouse hepatoma T 28012)
and their activation by 2: 4-DNP.
Isolation in 0 25 M sucrose containing 0 001 M EDTA (pH 7-4) 0 04 mg. mitochondrial
N per flask. Compare Fig. 1.
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Fie. 4.-The effect of aged albumin on tumour mitochondrial ATPases (mouse adrenal cortex
carcinoma T 17572) and their activation by 2: 4-DNP.
Isolation in 0 25M sucrose containing 0 001 M EDTA (pH 7. 4) 0 12 mg.N per flask.
0 0 controls, 0 -O 2: 4-DNP (10-4 M) present, 0----- aged
albumin present (2 per cent), 0- - - -0 aged albumin 'plus 2: 4-DNP present.STUDIES ON TUMOUR MITOCHONDRIA
Phosphate releasefrom ADP and ATP catalysed by mitochondrial sub-fractions
Myokinase can be obtained in a soluble form by disrupting liver mitochondria
(Kielley and Kielley, 1951, 1953), while the "ATPase" remains bound to the
sedimentable mitochondrial d6bris. Any appreciable Pi release from ADP will
thus only be possible when the soluble and sedimented parts of the disrupted
liver mitochondria are incubated together. This is clearly illustrated by the
experiments listed in Table VII which were carried out with mouse liver mito-
chondrial sub-fractions obtained by disrupting the mitochondria, as described
under Material and Methods, and centrifugation for 30 minutes at 20,000 >X g
at pH 7.4. Centrifugation at pH 5.0 did not change the results. The synergistic
action between the two sub-fractions in liberating Pi from ATP may be readily
explained on account of the myokinase activity of the soluble fraction which
removes the ADP that is inhibitory to the "ATPase" (Kielley and Kielley, 1953).
Table VII.-Phosphatereleasefrom ADPandATP Calalyzed byLiverMitochondrial
Sub-fractions.
I = sedimented fraction and 2 = soluble fraction of disrupted mito-
chondria; 1 + 2 = fractions combined after separation. In Experiments
a and b centrifugation was carried out at pH 7-4, in Experiment c at pH
5-0; compare under Materials and Methods. Experiments b and c were
performed with the same batch but not the same amount of disrupted
mitochondria.
tg. P2 released per flask after
20 minutes (by fraction) mg. N/flask
Experiment Substrate 1 2 1 +2 1 2
{ADP 31 6 10
a {ATP 102 16 104 0-27 0-10 ATP . 102 16 165'
f ADP . 10 5 1251 ~b . {ATP 155 32 232} 0*16 016
c . ATP 127 10 98} 0-.26 0-16 ATP . 127 10 200'
Similar experiments were also carried out with the sub-fractions prepared
from the tumour mitochondria. The first three experiments listed in Table VIII
show that no synergistic action in liberating Pi either from ADP or ATP could
be observed on mixing the two sub-fractions. This was apparently due to the lack
of separation since the myokinase camne down with the sedimented fraction. This
occurred irrespective of the fact whether the centrifugation was carried out at
pH 5-0 or 7-4. After centrifugation at 7-4 the supernatant was somewhat turbid.
The pH was therefore changed to 5-0; this resulted in a clear supernatant.
Judging from the nitrogen content of two sub-fractions it appeared also that
only a small part of the particulate material became soluble in the case of the
tumour mitochondria.
Evidently, either the tumour mitochondria contained less soluble material
or the disruption was far from complete. The latter may not be unreasonable
since the size of the tumour mitochondria was usually smaller than that of the
liver mitochondria. Therefore hepatoma mitochondria were used which were
approximately equal in size to the liver mitochondria. In this case (T28012)
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TABLE VIII.-Phosphate Release from ADP and ATP Catalyzed by Tumour
Mitochondrial Sub-fractions
(Compare Table VII)
Experiment a: Mitochondria isolated in sucrose-EDTA. Separation of
sub-fractions by centrifugation at pH 7-4; Experiment b: ibidem at pH
5-0; Experiments c and d: mitochondria isolated inthe absence ofEDTA,
separation of sub-fractions at pH 5,0; Experiments e andf: same batch
of mitochondria, isolated in sucrose-EDTA, separation of sub-fractions at
pH 5.0; during the treatment with distilled water 10-4 M Na-dodecyl-
sulphate was present in Experiment f.
,ug. Pi released per flask
after 20 minutes
(by fraction) mg. N/flask
Experi- Mitochondria , --_
ment from Substrate 1 2 1+2 1 2
a T5358 (testicular car- ADP 1 22 92 0.15 0.05
cinoma) ATP 140 26 157 cinema)
f ADP 132 0 141 b . T17572 (adrenal cortex ATP 1 0 180 023 -* carcinoma)ATP . 176 0 180J carcinoma)
f ADP 125 2 143k~ . R733(ovariantumour ATP 1200 212' 0-14 0.03
rat) ~~ATP . 200 3 212J rat) -
d . T28012 (hepatoma) ADP 52 5 0-21 004 ATP 112 5 119
ADP 35 9 62 0-12 002
ATP 88 20 1161
ADP .. 32 3 0-16 0.08
{ATP 120 32 152 '
* Sample lost.
not withstanding the small amount of soluble nitrogen some synergism was found
between the two sub-fractions in liberating Pi from ADP but not such an effect
was seen with ATP. The results of the latter experiment could be readily repro-
duced with other tumours of the same strain but the mitochondria from another
hepatoma (T26473) yielded negative results.
The final elucidation of this problem awaits further investigation of tumour
mitochondria disrupted by other means and the application of higher centrifugal
forces.
Our type of liver mitochondrial sub-fractions was apparently different from
that of Keilley and Kielley (1953). These authors found that on disrupting liver
mitochondria in a Waring blendor, about 60-70 per cent of the ATPase activity
released was recovered in the supernatant after centrifugation at 20,000 x g
and that 80-90 per cent of this activity was in turn recovered in the pellet after
centrifugation at 110,000 x g. Since our ATPase preparation from the disrupted
liver mitochondria was almost completely sedimentable at 20,000 x g, it is evident
that in the present work the mitochondria were not broken down to such small
fragments as in the experiments of the American authors.
Oxidative phosphorylation by tumour mitochondria
It has not been possible to obtain satisfactory oxidation ofBHB by the tumour
mitochondria which show high ATP- and DPN-splitting activities (sarcoma
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UV256, adrenal cortex carcinoma T17572, etc.) The only possible exception is
provided by the mitochondria from the hepatoma T26473 which may be classified
however on other grounds as the least representative of this group of tumours
(Emmelot and Bos, 1955a, 1956b).
Most of the other tumour mitochondria exhibiting smaller ATP- and DPN-
splitting activities than the former, show a satisfactory oxygen uptake in the
presence of D-BHB but are unable to oxidize L-BHB. This oxidation of D-BHB,
like that of citric acid cycle intermediates as shown for other tumour mitochondria
(Williams-Ashman and Kennedy, 1952; Kielley, 1952; Lindberg et al., 1953;
Potter and Siekeviz, 1951) is accompanied by phosphorylation. In the absence of
fluoride low P: 0 ratios, but in the presence of fluoride (0.01 M) P: 0 ratios of
over 2 were obtained as illustrated in Table IX. The action offluoride in inhibiting
the tumour mitochondrial myokinase and "ATPase ", which enzymes would
otherwise make any net phosphate uptake difficult to demonstrate, is very clearly
illustrated in the experiment with the mitochondria from T26473 (compare
Table V). Some control experiments on the effect of fluoride on the phosphate
release from ATP and ADP by tumour mitochondria over a 15-minute period
did indeed show that the "ATPases" were inhibited for 50-60 per cent and the
myokinases for 80-100 per cent.
In a few cases the mitochondria from the sarcoma UV256 effected a small
oxidation of pyruvate in the presence of L-malate and DPN. The P: 0 ratio
found was half of that obtained with the mitochondria from the ovarian tumour
T5441 or the testicular tumour T26554. This again demonstrated the difference
in biochemical integrity between the representative of the two groups of tumour
mitochondria.
TABLE IX.-Phosphorylation Accompanying the Oxidation of DL-BHB and
Pyruvate by Tumour Mitochondria
Experimental conditions as in Table II, except that tumour mitochondria
(approximating 0.5-0.7 mg. N) 21 ,u-moles Pi and 16 ,u-moles NaF were
present. In four experiments 2 tu-moles pyruvate and 0.5 p-mole
L-malate were added.
Mitochondria -Pi - AO
from Substrate ,u-moles ,u-atoms P: O
T 5358 (testicular carcinoma) . DL-BHB . 4.3 . 1.9 . 2.3
T26473 (hepatoma) . ,, 6-9 2-4 . 2.9
T28102 (hepatoma) . ,, . 7-7 . 3.7 2-1
T 5441 (ovarian tumour) Pyruvate+L-malate 4 0 . 2-5 . 1-6
UV 256 (sarcoma) ,, ,, . 1-2 . 1.5 . 0-8
T26554 (testicular tumour) . ,, ,, . 10-7 . 5-8 . 1-8
CBA71 (hepatoma) . ,, ,, . 10-8 . 5-4 2-0
SUMMARY
It has been shown that sucrose-EDTA prepared mitochondria from certain
tumour strains uncouple the phosphorylations normally associated with the
oxidation of D-/-hydroxybutyrate by liver mitochondria, when both types of
mitochondria are incubated together in the presence of DL-fl-hydroxybutyrate
and DPN. Consequently, the ATP-dependent oxidation of L-/-hydroxybutyrate,
and in analogy that of octanoate, is abolished in a combined liver-tumour mito-
chondrial system. The tumour mitochondria possessed very pronounced "ATP-
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ase" and myokinase activities as shown by the release of inorganic phosphate
from ADP. In contrast, mitochondria from a number of other tumours, which
have been shown earlier to be biochemically more intact than the former mito-
chondria (e.g. "ATPases ", DPNases and TPNases less active and no inhibition
of the ATP- or DPN-dependent oxidative processes of the liver mitochondria)
released much less inorganic phosphate from ADP. The latter tumour mito-
chondria yielded P: 0 ratios from 2-3 in the presence of DL-,8-hydroxybutyrate
or pyruvate when fluoride was added.
Myokinase and "ATPase" activities could easily be separated by disruption
of liver mitochondria and centrifugation but in the case of tumour mitochondria
results were unsatisfactory.
Addition of2per centfresh human serum y-globulin suppressed the " ATPase"
activities of both liver and tumour mitochondria. Under these conditions an
activation of the tumour mitochondrial "ATPases" by 2: 4-dinitrophenol could
readily be demonstrated. An aged preparation of human serum albumin, unlike
fresh albumin, activated the enzymes of both types of mitochondria very signifi-
cantly.
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